NO and pulmonary arterial hypertension;

Pharmacology and clinical study of ambrisentan for treatment of pulmonary arterial hypertension;

Clinic Study on Shenfu Injection to Treat Pulmonary Arterial Hypertension of Chronic Cardiopulmonary Disease;

Effects of Enalapril or Metoprolol on plasm brain natriuretice peptide in congenital heart disease combined with pulmonary artery hypertension after transcatheter closure;

Preparation and identification of animal model with hypoxia-induced pulmonary artery hypertension;

Clinical observation on the left ventricular myocardial remodel and dysfunction in children with congenital heart disease and hypoxia-induced pulmonary artery hypertension.;

Effects of fasudil on hypoxia-induced pulmonary hypertension and vascular remodeling in rats;

Role of endogenous hydrogen sulfide in pulmonary hypertension induced by lipopolysaccharide;

Treatment of patent ductus arteriosus accompanied with severe pulmonary hypertension with transcatheter occlusion;

The Association of Polymorphism of Endothelial Nitric Oxide Synthase Gene in Patients with PAH of Chronic Obstructive Pulmonary Disease;

On Correlation between Syndrome of Sinking of Pectoral Qi and PAH;

The Research of the Applying Value of PG in the Diagnosis and Therapy of PAH by PHD;